相关实验视频

Updated: May 1, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

11.9K

在转移性前列腺癌中使用-223的巴西概况:一个多中心,回顾性研究

Stephan Souza1, Felipe Ribeiro1, Ana Brito2

  • 1University of Campinas (UNICAMP), Campinas, Brazil.

EJNMMI reports
|April 23, 2025
PubMed
概括

-223 (223Ra) 疗法显示,转移性割抗性前列腺癌 (mCRPC) 患者的整体存活率 (OS) 高,完成了6个周期. 然而,巴西的区域差异表明患者管理中的潜在问题可能会影响最大的OS益处.

关键词:
总体生存率 总体生存率没有进展的生存率.前列腺癌是什么意思 前列腺癌是什么意思-2233是一种.与骨相关的事件

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

12.9K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

9.6K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K